deltatrials

Wellspect HealthCare Clinical Trials

Sponsors / Wellspect HealthCare

Wellspect HealthCare appears as lead sponsor on 23 trial records in ClinicalTrials.gov. The portfolio currently includes 1 recruiting studies, 0 active non-recruiting studies, and 18 completed studies. 3 trials in this portfolio were terminated or withdrawn before completion. The most common reasons cited for termination include efficacy or futility findings, slow or insufficient recruitment. Cumulative planned enrollment across all listed trials is 1,740 participants. These counts reflect the current state of the public ClinicalTrials.gov registry.

23
Total Trials
1
Recruiting
0
Other Active
18
Completed
3
Terminated / Withdrawn
1,740
Total Enrollment

Termination reasons: Other33% · Efficacy33% · Recruitment33%

Recent Terminations

  • NCT04703413 Phase NA Stopped Apr 2023
    Bladder Voiding Dysfunction
    "Insufficient recruitment"
  • NCT01600443 Phase NA Stopped May 2012
    Hematuria
    "Planned interim analysis showed study was underpowered"
  • NCT00913510 Phase NA Stopped May 2012
    Bladder Dysfunction

Active Trials (0 total)

Top Conditions

Top Locations